Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ads free!Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ads free today!Spring sale! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
Tech
Science

Cystic Fibrosis
Health
Cancer
Mental Health
Reproductive Health
Obesity
Topics

Advertisement

Cystic Fibrosis

Share

Top Latest Popular

Glow Ride to fight cystic fibrosis takes place Saturday, May 9 Media News Group 7d

Media News Group 7d

Los Angeles California

Colourful 5K sees Stroud pupils support friend with cystic fibrosis Stroud News & Journal, Gloucestershire 05:18 Thu, 30 Apr

Stroud News & Journal, Gloucestershire 05:18 Thu, 30 Apr

Internal nanobodies tackle cystic fibrosis Forbes 2d

Forbes 2d

Advertisement

Advertisement

New strategy targets antibiotic resistance in cystic fibrosis Drug Target Review 08:17 Thu, 23 Apr

Drug Target Review 08:17 Thu, 23 Apr

Texas Schools Global Health

Bundoran Library to host exhibition highlighting Cystic Fibrosis Donegal News 2d

Donegal News 2d

County Limerick County Donegal

Rep. of Ireland

Great Strides walk in Bettendorf to support those with cystic fibrosis KWQC 23:57 Sun, 03 May

KWQC 23:57 Sun, 03 May

Advertisement

Advertisement

Latest

In the last 4 hours

Major fundraiser event to support four-year-old with rare condition Hampshire Chronicle 12:20

Enterprise’s Phase II trial of ETD001 meets primary endpoint in pwCF Clinical Trials Arena 11:44

In the last 8 hours

Celebrating 10 years of Cherry Ward Liverpool Heart and Chest Hospital (Press Release) 08:09

Earlier Today

Meet the 'little superhero' battling incredibly rare condition Daily Echo 03:53

Yesterday

Enterprise reports positive phase 2 data for inhaled ENaC blocker in cystic fibrosis PharmaTimes 11:30 Tue, 12 May

IP Group portfolio company Enterprise Therapeutics reports positive phase II results in cystic fibrosis Proactive Investors (UK) 10:30 Tue, 12 May

IP Group portfolio company Enterprise Therapeutics reveals positive cystic fibrosis trial results Proactive Investors (UK) 10:20 Tue, 12 May

Enterprise Therapeutics Achieves Primary Efficacy Outcome in Phase 2 Clinical Trial for Cystic Fibrosis With Novel Inhaled ENaC Blocker ETD001 Business Wire (Press Release) 09:39 Tue, 12 May

'My son has cystic fibrosis. The government wrongly denied him PIP – twice' Big Issue 07:39 Tue, 12 May

Monday

Bundoran Library to host exhibition highlighting Cystic Fibrosis Donegal News 17:02 Mon, 11 May

Advertisement

Advertisement

Advertisement

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Health Health
Back to Lifestyle Health
- Cancer Cancer
- Infectious Diseases
- Mental Health
- Neurological Diseases
- Obesity Obesity
- Rare Diseases
- Reproductive Health